R.PR
REGISTERED-PRINCIPAL REGISTER
01/04/2022
Back to search
Official data from USPTO
REVITOPE ONCOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
REVITOPE ONCOLOGY
ST13
US500000090430409Class
42
Filing
90430409
Registration
6605913
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
01/04/2022
Trademark type
Word
Nice classes
42
Filing date
12/30/2020
Registration date
01/04/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/04/2022
Last transaction
01/04/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2016-01-00
First use in commerce
2016-01-00
Drawing code
4
Owner type
03
Owner location
Cambridge, MA
Examiner
REEVES, APRIL
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Revitope Oncology, Inc.
Representatives
MONICA RIVA TALLEY STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Development of pharmaceutical preparations for the treatment of cancer; development of platform technologyimmunotherapy platforms for manufacturing cancer therapeutics; scientific research servicesantibody engineering for analytical and clinical purposes
Publications
History of USPTO decisions and trademark events.
15 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/19/2021
PUBO
PUBLISHED FOR OPPOSITION
10/19/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/29/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/14/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
09/14/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/14/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
09/14/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/14/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/11/2021
GNRT
NON-FINAL ACTION E-MAILED
07/11/2021
CNRT
NON-FINAL ACTION WRITTEN
07/11/2021
DOCK
ASSIGNED TO EXAMINER
06/20/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/24/2021
NWAP
NEW APPLICATION ENTERED
01/02/2021
Continuous trademark protection
Get notified about every new filing that threatens REVITOPE ONCOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.